These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 2486418)

  • 1. [New quinolones: similarities and differences].
    Levi GC
    AMB Rev Assoc Med Bras; 1989; 35(5):202-6. PubMed ID: 2486418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The new quinolones].
    Lontie M
    J Pharm Belg; 1989; 44(4):292-301. PubMed ID: 2691640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The place of quinolones in bacterial infections.
    Neu HC
    Adv Intern Med; 1991; 36():1-32. PubMed ID: 2024577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enrofloxacin in salmonids.
    Bowser PR; Babish JG
    Vet Hum Toxicol; 1991; 33 Suppl 1():46-8. PubMed ID: 1926748
    [No Abstract]   [Full Text] [Related]  

  • 5. New quinolones--in vivo antibacterial activity.
    Goto S; Miyazaki S
    Prog Drug Res; 1992; 38():29-37. PubMed ID: 1609116
    [No Abstract]   [Full Text] [Related]  

  • 6. [Quinolones: new synthetic antimicrobial agents].
    Lopes HV
    AMB Rev Assoc Med Bras; 1988; 34(2):54-60. PubMed ID: 3072599
    [No Abstract]   [Full Text] [Related]  

  • 7. [New quinolones, current therapies].
    Auckenthaler R
    Schweiz Rundsch Med Prax; 1988 Nov; 77(45):1217-8. PubMed ID: 2847274
    [No Abstract]   [Full Text] [Related]  

  • 8. Quinolones in perspective.
    Neu HC
    J Antimicrob Chemother; 1990 Oct; 26 Suppl B():1-6. PubMed ID: 2258336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Quinolones. Gyrase inhibitors].
    Höffler D
    Internist (Berl); 1994 May; 35(5):484-9. PubMed ID: 8021119
    [No Abstract]   [Full Text] [Related]  

  • 10. In vitro activity of new quinolones against anaerobic bacteria.
    Nord CE; Lindmark A; Persson I
    Drugs; 1995; 49 Suppl 2():233-4. PubMed ID: 8549314
    [No Abstract]   [Full Text] [Related]  

  • 11. Quinolones: which generation for which microbe?
    Lee MK; Kanatani MS
    West J Med; 1999 Jun; 170(6):359-61. PubMed ID: 10443165
    [No Abstract]   [Full Text] [Related]  

  • 12. The quinolones.
    Neu HC
    Infect Dis Clin North Am; 1989 Sep; 3(3):625-39. PubMed ID: 2671143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The future of the quinolones.
    Andriole VT
    Drugs; 1999; 58 Suppl 2():1-5. PubMed ID: 10553697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of oral fluoroquinolones as an alternative to traditional parenteral therapy for patients with serious infections.
    Ball P
    Clin Invest Med; 1989 Feb; 12(1):69-70. PubMed ID: 2920483
    [No Abstract]   [Full Text] [Related]  

  • 15. [New antibacterial agents].
    Järvinen A; Valtonen V
    Duodecim; 2000; 116(24):2803-5. PubMed ID: 12077883
    [No Abstract]   [Full Text] [Related]  

  • 16. The evolution of fluorinated quinolones: pharmacology, microbiological activity, clinical uses, and toxicities.
    Siporin C
    Annu Rev Microbiol; 1989; 43():601-27. PubMed ID: 2679364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Quinolones].
    Lode H
    Schweiz Med Wochenschr; 1988 Dec; 118(49):1823-30. PubMed ID: 3064290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metronidazole, clindamycin, and quinolones.
    Hammill HA
    Obstet Gynecol Clin North Am; 1989 Jun; 16(2):317-28. PubMed ID: 2674799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New quinolones in clinical practice.
    MacGowan AP
    Hosp Med; 1999 Apr; 60(4):309. PubMed ID: 10396443
    [No Abstract]   [Full Text] [Related]  

  • 20. Rufloxacin (MF-934): in vitro and in vivo antibacterial activity.
    Ravizzola G; Pinsi G; Pirali F; Colombrita D; Foresti I; Peroni L; Turano A
    Drugs Exp Clin Res; 1989; 15(1):11-5. PubMed ID: 2743869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.